Sabrina Brana, MD
Internal Medicine · Camarillo
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 7 years
- Graduated 2019
Offices
2 locations · Dignity Health Medical Foundation · 1,211 clinicians in this group
Hospitals listed: 058059 · St Johns Regional Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Brana’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A163040 · Current
Licensed to practise in California · since 2019 · expires 2027-06-30 · Georg-August-University of Gottingen Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Internal Medicine
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 96.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- St Johns Regional Medical CenterOxnard, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 68% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Death rate among surgical inpatients with serious treatable complications: 130.06 (90.32 to 169.81) · 120 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.404, Oct 2024 – Sep 2025
See every measure and the patient survey for St Johns Regional Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 9 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 130.06 (90.32 to 169.81) · 120 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.404 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.8 (0 to 1.75) · 1,494 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.85 (0.56 to 1.14) | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 40 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.8 · 159 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 8.7 · 279 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.1 · 580 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.6 · 654 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.6 · 380 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 3,404 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.18 (0 to 0.37) · 8,124 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.2 (0.01 to 0.39) · 8,331 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.92 (1.89 to 5.95) · 1,414 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.17 (0.6 to 3.75) · 412 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.94 (0.46 to 3.43) · 1,361 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.75 (0.73 to 12.78) · 439 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.94 (3.39 to 10.49) · 383 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.94 (0.47 to 3.41) · 325 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.11 (0 to 0.67) · 7,172 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 88 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.236 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.331 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.571 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.737 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 336 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.8 · 715 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -8.1 · 284 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.6 · 648 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -9.1 · 674 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.9 · 670 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (5.2 to 8.9) · 428 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.8 (8.6 to 13.5) · 428 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.9 · 98 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.3 · 49 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.1 · 196 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (10.5 to 18.8) · 247 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 486 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,151 patients answered, 18% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 83% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$115,778
Medicare paid this office $115,778 for 234 people. Most of that is long return visits and Botox.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 186 | $69,815 | $143 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 97 | $13,285 | $137 |
| New patient visit (60+ min) | 82 | $12,509 | $153 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 150 | $3,235 | $13 |
| Transitional care management services for problem of at least moderate complexity | 15 | $2,667 | $178 |
See all 11 services
| Long return visit (40+ min) | 186 | $69,815 | $143 |
| Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 97 | $13,285 | $137 |
| New patient visit (60+ min) | 82 | $12,509 | $153 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 150 | $3,235 | $13 |
| Transitional care management services for problem of at least moderate complexity | 15 | $2,667 | $178 |
| Return visit (30+ min) | 21 | $2,250 | $107 |
| Annual depression screening, 5 to 15 minutes | 106 | $2,208 | $21 |
| Injection of drug or substance under skin or into muscle | 45 | $931 | $11 |
| Administration of influenza virus vaccine | 12 | $411 | $34 |
| Hemoglobin a1c level | 22 | $276 | $10 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 41 | $68 | None |
Who their Medicare patients are
234 Original Medicare patients in 2024. Average age 76 · Women 68% · Also on Medicaid 11% · Health risk score 1.23. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Coronary heart disease 32% · Chronic kidney disease 26% · Diabetes 23% · Atrial fibrillation 21% · Cancer 19% · COPD 19% · Depression 19% · Heart failure 18% · Stroke 10% · Dementia 6%.
The office billed $380,113, Medicare allowed $149,802 and paid $115,778; for 1,510 services of 39 kinds; $5,478 of it was for drugs given in the office and $110,299 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 234 | 1,510 | 76 | 1.23 | $380,113 | $115,778 |
| 2023 | 145 | 461 | 74 | 1.22 | $158,180 | $52,210 |
| 2022 | 414 | 1,758 | 79 | 2.23 | $406,254 | $182,530 |
| 2021 | 329 | 1,319 | 79 | 2.52 | $377,686 | $118,385 |
| 2020 | 188 | 605 | 75 | 2.70 | $418,445 | $50,093 |
| 2019 | 42 | 107 | 77 | 3.23 | $71,193 | $8,374 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Long return visit (40+ min) | 120 | $37,752 | $140 |
| New patient visit (60+ min) | 35 | $5,932 | $169 |
| Return visit (30+ min) | 12 | $1,233 | $88 |
| Hemoglobin a1c level | 14 | $228 | $10 |
| Urinalysis, manual test | 13 | $51 | $3 |
2022: 12 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 200 | $60,283 | $86 |
| Long return visit (40+ min) | 131 | $44,668 | $142 |
| Critical care, first 30-74 minutes | 29 | $15,337 | $178 |
| Hospital discharge day management, more than 30 minutes | 137 | $13,456 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 75 | $13,305 | $166 |
| New patient visit (60+ min) | 79 | $13,202 | $167 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $6,628 | $60 |
| Advance care planning, first 30 minutes | 74 | $6,609 | $65 |
| Return visit (30+ min) | 18 | $1,613 | $85 |
| Advance care planning, first 30 minutes | 17 | $1,152 | $68 |
| Influenza vaccine split virus, preservative free | 14 | $960 | $69 |
| Administration of influenza virus vaccine | 14 | $343 | $25 |
2021: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 228 | $60,402 | $87 |
| Hospital discharge day management, more than 30 minutes | 150 | $14,145 | $91 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 48 | $10,913 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 56 | $9,801 | $169 |
| Critical care, first 30-74 minutes | 23 | $7,275 | $182 |
| Advance care planning, first 30 minutes | 72 | $6,708 | $66 |
| New patient visit (60+ min) | 14 | $2,700 | $193 |
| Hospital observation care on day of discharge | 12 | $739 | $62 |
2020: 7 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 105 | $24,814 | $89 |
| Hospital discharge day management, more than 30 minutes | 88 | $8,456 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 62 | $8,167 | $61 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,430 | $171 |
| Advance care planning, first 30 minutes | 15 | $1,075 | $67 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 13 | $895 | $33 |
| Hospital observation care on day of discharge | 12 | $749 | $62 |
2019: 3 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 22 | $4,252 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,761 | $61 |
| Hospital discharge day management, more than 30 minutes | 12 | $1,086 | $90 |
Medicaid work
$2,482 in 2024
Medicaid paid $2,482 for 62 billed services this clinician did in 2024, up to 17 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 62 | $2,482 |
| 2024 | 62 | 1 | 17 | $2,482 |
| 2021 | 71 | 1 | 18 | $4,469 |
| 2020 | 351 | 3 | 19 | $18,919 |
| 2019 | 68 | 1 | 14 | $3,689 |
See the largest Medicaid services in earlier years
2021
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 71 | $4,469 |
2020
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 244 | $13,387 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 62 | $3,648 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 45 | $1,885 |
2019
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 68 | $3,689 |
Drugs they prescribed that Part D paid
$394,115
Pharmacies billed $394,115 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (103 of 2,505) in 2024. Above the middle of the specialty; the typical internal medicine clinician is at 1%.
2,029 generic and fewer than 11 brand-name prescriptions · $394,115 in drug cost · 132 antibiotic prescriptions to 77 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Mounjaro | 91 | $111,569 | $1,226 |
| Ozempic | 22 | $23,252 | $1,057 |
| Rybelsus | 13 | $22,777 | $1,752 |
| Xigduo Xr | 16 | $22,248 | $1,391 |
| Xarelto | 26 | $21,839 | $840 |
See all 68 drugs
| Mounjaro | 91 | $111,569 | $1,226 |
| Ozempic | 22 | $23,252 | $1,057 |
| Rybelsus | 13 | $22,777 | $1,752 |
| Xigduo Xr | 16 | $22,248 | $1,391 |
| Xarelto | 26 | $21,839 | $840 |
| Trelegy Ellipta | 31 | $18,744 | $605 |
| Jardiance | 14 | $18,146 | $1,296 |
| Eliquis | 12 | $8,065 | $672 |
| Dapagliflozin-Metformin Er | 12 | $5,972 | $498 |
| Atorvastatin | 152 | $1,742 | $11 |
| Lidocaine | 15 | $1,641 | $109 |
| Levothyroxine | 88 | $1,624 | $18 |
| Pantoprazole | 63 | $1,129 | $18 |
| Lantus Solostar | 12 | $1,045 | $87 |
| Omeprazole | 36 | $1,002 | $28 |
| Bupropion Xl | 25 | $994 | $40 |
| Albuterol Sulfate Hfa | 37 | $889 | $24 |
| Synthroid | 13 | $867 | $67 |
| Rosuvastatin | 71 | $838 | $12 |
| Losartan | 77 | $809 | $11 |
| Ezetimibe | 30 | $774 | $26 |
| Zolpidem | 13 | $737 | $57 |
| Nateglinide | 13 | $717 | $55 |
| Lisinopril | 67 | $633 | $9 |
| Mirtazapine | 20 | $600 | $30 |
| Amlodipine Besylate | 63 | $573 | $9 |
| Nifedipine Er | 16 | $555 | $35 |
| Gabapentin | 31 | $529 | $17 |
| Hydrocodone-Acetaminophen | 26 | $509 | $20 |
| Duloxetine | 17 | $493 | $29 |
| Potassium Chloride | 17 | $395 | $23 |
| Escitalopram | 18 | $389 | $22 |
| Valsartan | 12 | $388 | $32 |
| Metformin | 38 | $364 | $10 |
| Eszopiclone | 16 | $337 | $21 |
| Pregabalin | 11 | $322 | $29 |
| Losartan-Hydrochlorothiazide | 14 | $321 | $23 |
| Famotidine | 20 | $316 | $16 |
| Nitrofurantoin Mono-Macro | 22 | $314 | $14 |
| Oxycodone | 13 | $278 | $21 |
| Furosemide | 35 | $255 | $7 |
| Diclofenac | 15 | $250 | $17 |
| Metoprolol | 24 | $248 | $10 |
| Amoxicillin-Clavulanate Potass | 23 | $220 | $10 |
| Ibuprofen | 22 | $204 | $9 |
| Tramadol | 52 | $193 | $4 |
| Fluticasone Propionate | 15 | $193 | $13 |
| Trazodone | 25 | $180 | $7 |
| Clonazepam | 15 | $178 | $12 |
| Fluoxetine | 16 | $172 | $11 |
| Metformin Hcl Er | 16 | $161 | $10 |
| Pravastatin | 12 | $161 | $13 |
| Tizanidine | 13 | $154 | $12 |
| Cyclobenzaprine | 13 | $152 | $12 |
| Sertraline | 29 | $144 | $5 |
| Alprazolam | 25 | $132 | $5 |
| Buspirone | 15 | $126 | $8 |
| Azithromycin | 27 | $123 | $5 |
| Hydrochlorothiazide | 31 | $120 | $4 |
| Simvastatin | 12 | $115 | $10 |
| Triamterene-Hydrochlorothiazid | 11 | $101 | $9 |
| Doxycycline Hyclate | 11 | $97 | $9 |
| Carvedilol | 13 | $91 | $7 |
| Atenolol | 11 | $85 | $8 |
| Hydralazine | 12 | $71 | $6 |
| Warfarin | 16 | $50 | $3 |
| Prednisone | 11 | $49 | $4 |
| Levofloxacin | 13 | $32 | $2 |
Year by year
| 2024 | 2,505 | 277 | 4% (103) | None | $394,115 |
| 2023 | 1,269 | 257 | 1% (18) | 19% | $203,913 |
| 2022 | 1,374 | 273 | 3% (34) | 15% | $141,273 |
| 2021 | 385 | 117 | 5% (20) | 17% | $27,692 |
| 2020 | 421 | 107 | 3% (12) | None | $21,578 |
| 2019 | 1,178 | 125 | 0% (0) | 24% | $95,383 |
| 2018 | 1,409 | 168 | 0% (0) | 28% | $189,622 |
| 2017 | 1,525 | 119 | None | 24% | $108,778 |
| 2016 | 62 | 16 | 0% (0) | None | $4,557 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 34 drugs
| Ozempic | 37 | $45,175 | $1,221 |
| Trulicity | 13 | $27,291 | $2,099 |
| Rybelsus | 21 | $25,014 | $1,191 |
| Rosuvastatin | 57 | $2,093 | $37 |
| Zolpidem | 25 | $1,172 | $47 |
| Levothyroxine | 62 | $1,007 | $16 |
| Mirtazapine | 22 | $996 | $45 |
| Atorvastatin | 58 | $687 | $12 |
| Ezetimibe | 12 | $610 | $51 |
| Pantoprazole | 33 | $577 | $17 |
| Gabapentin | 27 | $563 | $21 |
| Montelukast | 12 | $562 | $47 |
| Albuterol Sulfate Hfa | 18 | $494 | $27 |
| Synthroid | 11 | $443 | $40 |
| Lisinopril | 35 | $375 | $11 |
| Escitalopram | 27 | $370 | $14 |
| Metformin | 32 | $294 | $9 |
| Losartan | 18 | $267 | $15 |
| Spironolactone | 14 | $253 | $18 |
| Tamsulosin | 14 | $237 | $17 |
| Verapamil Er | 12 | $210 | $18 |
| Atenolol | 12 | $208 | $17 |
| Hydrochlorothiazide | 22 | $181 | $8 |
| Famotidine | 16 | $168 | $10 |
| Alendronate | 14 | $158 | $11 |
| Amoxicillin-Clavulanate Potass | 12 | $142 | $12 |
| Alprazolam | 19 | $131 | $7 |
| Trazodone | 14 | $128 | $9 |
| Azithromycin | 21 | $124 | $6 |
| Furosemide | 14 | $124 | $9 |
| Carvedilol | 13 | $113 | $9 |
| Amlodipine Besylate | 19 | $109 | $6 |
| Metformin Hcl Er | 20 | $102 | $5 |
| Fluconazole | 15 | $76 | $5 |
2022: 32 drugs
| Eliquis | 26 | $17,054 | $656 |
| Ozempic | 14 | $15,319 | $1,094 |
| Xarelto | 13 | $8,511 | $655 |
| Rosuvastatin | 58 | $2,219 | $38 |
| Levothyroxine | 68 | $1,183 | $17 |
| Pantoprazole | 43 | $921 | $21 |
| Atorvastatin | 71 | $647 | $9 |
| Albuterol Sulfate Hfa | 13 | $561 | $43 |
| Duloxetine | 12 | $545 | $45 |
| Metoprolol | 18 | $383 | $21 |
| Gabapentin | 26 | $322 | $12 |
| Omega-3 Acid Ethyl Esters | 11 | $316 | $29 |
| Tamsulosin | 14 | $240 | $17 |
| Lisinopril | 49 | $218 | $4 |
| Alendronate | 19 | $217 | $11 |
| Amlodipine Besylate | 30 | $203 | $7 |
| Azithromycin | 26 | $202 | $8 |
| Losartan | 20 | $192 | $10 |
| Furosemide | 46 | $190 | $4 |
| Citalopram Hbr | 24 | $181 | $8 |
| Carvedilol | 20 | $172 | $9 |
| Zolpidem | 24 | $158 | $7 |
| Hydrochlorothiazide | 28 | $143 | $5 |
| Metformin Hcl Er | 15 | $142 | $9 |
| Alprazolam | 22 | $129 | $6 |
| Amoxicillin-Clavulanate Potass | 11 | $124 | $11 |
| Hydrocodone-Acetaminophen | 15 | $119 | $8 |
| Prednisone | 15 | $92 | $6 |
| Trazodone | 14 | $87 | $6 |
| Levofloxacin | 16 | $82 | $5 |
| Metformin | 15 | $66 | $4 |
| Tramadol | 13 | $64 | $5 |
2021: 5 drugs
| Eliquis | 11 | $6,585 | $599 |
| Atorvastatin | 25 | $254 | $10 |
| Pantoprazole | 14 | $128 | $9 |
| Furosemide | 32 | $125 | $4 |
| Levofloxacin | 14 | $105 | $7 |
2020: 8 drugs
| Pantoprazole | 23 | $199 | $9 |
| Atorvastatin | 25 | $177 | $7 |
| Levofloxacin | 14 | $149 | $11 |
| Levothyroxine | 11 | $124 | $11 |
| Furosemide | 24 | $99 | $4 |
| Carvedilol | 13 | $48 | $4 |
| Lisinopril | 14 | $45 | $3 |
| Amlodipine Besylate | 15 | $37 | $2 |
2019: 36 drugs
| Novolog Flexpen | 11 | $6,126 | $557 |
| Symbicort | 16 | $5,307 | $332 |
| Incruse Ellipta | 13 | $5,076 | $390 |
| Xarelto | 11 | $4,979 | $453 |
| Ventolin Hfa | 25 | $1,409 | $56 |
| Comfort Ez Pen Needle | 16 | $1,238 | $77 |
| Nifedipine Er | 38 | $742 | $20 |
| Albuterol Sulfate Hfa | 13 | $659 | $51 |
| Atorvastatin | 51 | $554 | $11 |
| Rosuvastatin | 34 | $380 | $11 |
| Famotidine | 46 | $355 | $8 |
| Ezetimibe | 13 | $234 | $18 |
| Omeprazole | 26 | $213 | $8 |
| Tamsulosin | 24 | $212 | $9 |
| Lisinopril | 66 | $192 | $3 |
| Gabapentin | 15 | $187 | $12 |
| Duloxetine | 13 | $184 | $14 |
| Amlodipine Besylate | 51 | $163 | $3 |
| Fluticasone Propionate | 17 | $158 | $9 |
| Metoprolol | 16 | $149 | $9 |
| Montelukast | 20 | $138 | $7 |
| Levothyroxine | 12 | $137 | $11 |
| Clopidogrel | 25 | $137 | $5 |
| Pantoprazole | 20 | $136 | $7 |
| Metoprolol | 24 | $131 | $5 |
| Metformin | 26 | $119 | $5 |
| Carvedilol | 16 | $114 | $7 |
| Ibuprofen | 11 | $107 | $10 |
| Simvastatin | 29 | $104 | $4 |
| Hydrochlorothiazide | 44 | $89 | $2 |
| Losartan | 20 | $61 | $3 |
| Furosemide | 22 | $54 | $2 |
| Trazodone | 12 | $50 | $4 |
| Alendronate | 16 | $46 | $3 |
| Single Use Swab | 17 | $39 | $2 |
| Meloxicam | 13 | $15 | $1 |
2018: 34 drugs
| Januvia | 23 | $13,336 | $580 |
| Symbicort | 26 | $8,130 | $313 |
| Advair Diskus | 19 | $7,715 | $406 |
| Lantus Solostar | 13 | $4,170 | $321 |
| Ventolin Hfa | 59 | $3,201 | $54 |
| Rosuvastatin | 43 | $2,137 | $50 |
| Proair Hfa | 21 | $1,292 | $62 |
| Comfort Ez Pen Needle | 11 | $803 | $73 |
| Nifedipine Er | 28 | $750 | $27 |
| Atorvastatin | 73 | $712 | $10 |
| Metoprolol | 31 | $543 | $18 |
| Alcohol Prep Pads | 18 | $420 | $23 |
| Montelukast | 33 | $299 | $9 |
| Enalapril Maleate | 15 | $283 | $19 |
| Levothyroxine | 25 | $283 | $11 |
| Gabapentin | 22 | $235 | $11 |
| Omeprazole | 44 | $196 | $4 |
| Tamsulosin | 21 | $173 | $8 |
| Lisinopril | 71 | $166 | $2 |
| Amlodipine Besylate | 46 | $160 | $3 |
| Isosorbide Mononitrate Er | 14 | $135 | $10 |
| Metoprolol | 31 | $127 | $4 |
| Simvastatin | 29 | $118 | $4 |
| Metformin | 34 | $100 | $3 |
| Fluticasone Propionate | 14 | $97 | $7 |
| Furosemide | 43 | $96 | $2 |
| Carvedilol | 21 | $95 | $5 |
| Famotidine | 16 | $93 | $6 |
| Losartan | 17 | $64 | $4 |
| Meloxicam | 25 | $57 | $2 |
| Prednisone | 14 | $47 | $3 |
| Alendronate | 13 | $40 | $3 |
| Hydrochlorothiazide | 20 | $36 | $2 |
| Single Use Swab | 12 | $26 | $2 |
2017: 42 drugs
| Januvia | 27 | $11,334 | $420 |
| Lantus Solostar | 24 | $7,606 | $317 |
| Novolog Flexpen | 11 | $5,770 | $525 |
| Incruse Ellipta | 17 | $5,429 | $319 |
| Symbicort | 18 | $5,423 | $301 |
| Flovent Hfa | 11 | $3,165 | $288 |
| Ventolin Hfa | 52 | $2,711 | $52 |
| Rosuvastatin | 24 | $2,167 | $90 |
| Proair Hfa | 16 | $906 | $57 |
| Metoprolol | 44 | $866 | $20 |
| Nifedipine Er | 24 | $863 | $36 |
| Atorvastatin | 68 | $664 | $10 |
| Pro Comfort Alcohol Pads | 13 | $537 | $41 |
| Oxybutynin Chloride Er | 13 | $479 | $37 |
| Sucralfate | 15 | $412 | $27 |
| Chlorthalidone | 12 | $408 | $34 |
| Polyethylene Glycol 3350 | 16 | $347 | $22 |
| Simvastatin | 53 | $320 | $6 |
| Metformin | 54 | $282 | $5 |
| Tamsulosin | 33 | $278 | $8 |
| Levothyroxine | 20 | $253 | $13 |
| Lisinopril | 82 | $249 | $3 |
| Alcohol Prep Pads | 15 | $246 | $16 |
| Hydralazine | 18 | $227 | $13 |
| Montelukast | 26 | $217 | $8 |
| Losartan | 34 | $202 | $6 |
| Omeprazole | 34 | $188 | $6 |
| Losartan-Hydrochlorothiazide | 12 | $146 | $12 |
| Amlodipine Besylate | 69 | $143 | $2 |
| Gabapentin | 22 | $126 | $6 |
| Latanoprost | 13 | $122 | $9 |
| Metoprolol | 31 | $111 | $4 |
| Baclofen | 13 | $106 | $8 |
| Clopidogrel | 18 | $88 | $5 |
| Alendronate | 19 | $66 | $3 |
| Furosemide | 29 | $59 | $2 |
| Carvedilol | 17 | $59 | $3 |
| Meloxicam | 22 | $56 | $3 |
| Hydrochlorothiazide | 21 | $51 | $2 |
| Famotidine | 11 | $43 | $4 |
| Glipizide | 11 | $26 | $2 |
| Metformin Hcl Er | 11 | $22 | $2 |
Money from drug and device companies
$462 in 2025
| 2025 | 7 | 24 | None | $462 |
| 2024 | 8 | 17 | None | $478 |
| 2023 | 3 | 4 | None | $110 |
| 2022 | 6 | 7 | None | $179 |
| 2020 | 1 | 3 | None | $23 |
| 2019 | 1 | 1 | None | $90 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Airsupra | $194 | 11 payments
|
| Amgen | Evenity | $70 | 3 payments
|
| Novo Nordisk | Wegovy | $61 | 3 payments
|
| Pfizer | Prevnar 20 | $49 | 2 payments
|
| Lilly USA | Mounjaro | $43 | 2 payments
|
| Exact Sciences | Cologuard Collection Kit | $25 | 1 payment
|
See all 23 published payments
| AstraZeneca Pharmaceuticals LP | Meals · 2025-12-09 | Airsupra | $23 |
| Amgen | Meals · 2025-12-09 | Evenity | $20 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-14 | Farxiga | $19 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-30 | Airsupra | $17 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-16 | Airsupra | $14 |
| Novo Nordisk | Meals · 2025-09-09 | None | $14 |
| Lilly USA | Meals · 2025-09-02 | Mounjaro | $21 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-19 | Farxiga | $20 |
| Amgen | Meals · 2025-08-04 | Evenity | $30 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-23 | Airsupra | $20 |
| GlaxoSmithKline | Meals · 2025-06-23 | Shingrix | $21 |
| Novo Nordisk | Meals · 2025-06-18 | Wegovy | $22 |
| Amgen | Meals · 2025-05-27 | Evenity | $21 |
| Pfizer | Meals · 2025-05-13 | Prevnar 20 | $25 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-06 | Airsupra | $15 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-11 | Farxiga | $16 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-26 | Airsupra | $16 |
| Novo Nordisk | Meals · 2025-02-11 | Wegovy | $24 |
| Pfizer | Meals · 2025-02-04 | Zavzpret | $24 |
| Lilly USA | Meals · 2025-01-28 | Mounjaro | $22 |
| Exact Sciences | Meals · 2025-01-21 | Cologuard Collection Kit | $25 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-13 | Farxiga | $15 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-07 | Breztri | $21 |
See earlier years (2024, 2023, 2022, 2020, 2019)
2024: $478
| Abbott Laboratories | Aveir | $127 | 1 payment
|
| Pfizer | Prevnar 20 | $89 | 4 payments
|
| Lilly USA | Taltz | $58 | 3 payments
|
| Amgen | Otezla | $47 | 2 payments
|
| Novo Nordisk | Wegovy | $44 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Fasenra | $43 | 2 payments
|
| Shield Therapeutics | Accrufer | $38 | 2 payments
|
| Ucb | Cimzia | $32 | 1 payment
|
2023: $110
| Shield Therapeutics | Accrufer | $73 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $19 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Tradjenta | $17 | 1 payment
|
2022: $179
| Lilly USA | Emgality | $59 | 2 payments
|
| Sanofi-Aventis U.S. | Soliqua 100/33 | $35 | 1 payment
|
| Mannkind | Afrezza | $23 | 1 payment
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $21 | 1 payment
|
| Novo Nordisk | Rybelsus | $21 | 1 payment
|
| Novartis Pharmaceuticals | Entresto | $20 | 1 payment
|
2020: $23
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $23 | 3 payments
|
2019: $90
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $90 | 1 payment
|
Professional record
- NPI
- 1790137388
- Licence
- CA A163040California A163040: Current · expires 2027-06-30
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Internal medicine (207R00000X)
- Mailing address
- 3400 Data Dr, Rancho Cordova, CA, 95670
- NPI first listed
- 2016-07-07
- NPI last updated
- 2024-01-05
- NPI record certified
- 2024-01-05
This is when the NPI record was last certified, not a medical board exam.